Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation
- 1 January 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 178 (1), 9-17
- https://doi.org/10.1016/j.atherosclerosis.2004.08.023
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationThe Journal of Experimental Medicine, 2002
- Novel Mode of Action of Angiotensin I Converting Enzyme InhibitorsPublished by Elsevier ,2002
- Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatmentJournal of Clinical Investigation, 2000
- NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in RatsHypertension, 2000
- Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin HypertensionHypertension, 1999
- Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction: Rapid CommunicationKidney International, 1997
- Ramipril Prevents Endothelial Dysfunction Induced by Oxidized Low-Density LipoproteinsHypertension, 1997
- Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalaprilAtherosclerosis, 1997
- Dissociation Between the Antiatherosclerotic Effect of Trandolapril and Suppression of Serum and Aortic Angiotensin-Converting Enzyme Activity in the Watanabe Heritable Hyperlipidemic RabbitHypertension, 1995
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994